Sanjay Koul

2.0k total citations
21 papers, 1.6k citations indexed

About

Sanjay Koul is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Sanjay Koul has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Sanjay Koul's work include Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Sanjay Koul is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Sanjay Koul collaborates with scholars based in United States, Colombia and Germany. Sanjay Koul's co-authors include Mahesh Mansukhani, Balázs Halmos, Xuewen Liu, Vundavalli V. Murty, Rekha Rao, Jianguang Chen, Kapil N. Bhalla, Warren Fiskus, Ramesh Balusu and Gopeshwar Narayan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Sanjay Koul

20 papers receiving 1.6k citations

Peers

Sanjay Koul
Vinay Sagar United States
Bryce P. Portier United States
Julian Schardt Switzerland
S. Michael Rothenberg United States
Jens Quant Austria
Yanli Su United States
S. Tiong Ong United States
Vinay Sagar United States
Sanjay Koul
Citations per year, relative to Sanjay Koul Sanjay Koul (= 1×) peers Vinay Sagar

Countries citing papers authored by Sanjay Koul

Since Specialization
Citations

This map shows the geographic impact of Sanjay Koul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Koul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Koul more than expected).

Fields of papers citing papers by Sanjay Koul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Koul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Koul. The network helps show where Sanjay Koul may publish in the future.

Co-authorship network of co-authors of Sanjay Koul

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Koul. A scholar is included among the top collaborators of Sanjay Koul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Koul. Sanjay Koul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Qiong, Antony B. Holmes, Tongwei Mo, et al.. (2024). MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis. Nature Communications. 15(1). 7195–7195. 1 indexed citations
2.
Pathak, Rahul, et al.. (2024). Unlocking the benefits of Drug Master File filing in the Indian pharmaceutical industries. Indian Journal of Pharmacology. 56(5). 342–347.
3.
Hisamori, Shigeo, Sanjay Koul, Takanori Hayashi, et al.. (2022). Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells. Journal of Gastroenterology. 57(6). 407–422. 5 indexed citations
4.
Sun, Yan, Stephanie Stransky, Jennifer T. Aguilan, et al.. (2021). High throughput and low bias DNA methylation and hydroxymethylation analysis by direct injection mass spectrometry. Analytica Chimica Acta. 1180. 338880–338880. 15 indexed citations
5.
Meyer, Stefanie N., Sanjay Koul, & Laura Pasqualucci. (2021). Mouse Models of Germinal Center Derived B-Cell Lymphomas. Frontiers in Immunology. 12. 710711–710711. 7 indexed citations
6.
Liu, Xuewen, Yuxia Jia, Yufeng Shen, et al.. (2015). Detection of frequent MET Exon 14 skipping events in pulmonary sarcomatoid carcinoma and response to targeted inhibition.. Journal of Clinical Oncology. 33(15_suppl). 8020–8020. 7 indexed citations
7.
Liu, Xuewen, Yuxia Jia, Mark Stoopler, et al.. (2015). Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations. Journal of Clinical Oncology. 34(8). 794–802. 242 indexed citations
8.
Wang, Xiaoqi, Guangyuan Li, Sanjay Koul, et al.. (2015). PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling. Oncotarget. 9(38). 24914–24926. 24 indexed citations
9.
Stellas, Dimitris, Matthias Szabolcs, Sanjay Koul, et al.. (2014). Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer. JNCI Journal of the National Cancer Institute. 106(12). 61 indexed citations
10.
Koul, Sanjay, et al.. (2011). New-onset headache in an elderly man with uremia that improved only after correction of hyperphosphatemia ("uremic headache"): a case report. Journal of Medical Case Reports. 5(1). 77–77. 6 indexed citations
12.
Fiskus, Warren, Rekha Rao, Aditya Mandawat, et al.. (2009). Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells. Cancer Biology & Therapy. 8(10). 939–950. 68 indexed citations
13.
Fiskus, Warren, Yongchao Wang, Arun Sreekumar, et al.. (2009). Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 114(13). 2733–2743. 292 indexed citations
15.
Koul, Sanjay, James M. McKiernan, Gopeshwar Narayan, et al.. (2004). Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.. Molecular Cancer. 3(1). 16–16. 116 indexed citations
16.
Narayan, Gopeshwar, Hugo Arias‐Pulido, Sanjay Koul, et al.. (2003). Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.. Molecular Cancer. 2(1). 24–24. 195 indexed citations
17.
Narayan, Gopeshwar, Hugo Arias‐Pulido, Sanjay Koul, et al.. (2003). Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression. Oncogene. 22(22). 3489–3499. 62 indexed citations
18.
Koul, Sanjay, Jane Houldsworth, Mahesh Mansukhani, et al.. (2002). Characteristic promoter hypermethylation signatures in male germ cell tumors.. Molecular Cancer. 1(1). 8–8. 88 indexed citations
19.
Naef, Félix, Pulivarthi H. Rao, Victor E. Reuter, et al.. (2002). Genomic and Expression Analysis of the 12p11-p12 Amplicon Using EST Arrays Identifies Two Novel Amplified and Overexpressed Genes. PubMed. 62(21). 6218–23. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026